Latest Boardroom Shifts News

Hastings Technology Metals appoints Vince Catania as CEO, entrusting him with advancing the Yangibana Rare Earths Project and broader portfolio development.

EVE Health Group has launched a $1.5 million capital raise alongside the acquisition of biotech firm Nextract, aiming to expand its footprint in health and pharmaceutical products focused on erectile dysfunction and period pain.

Tower Limited has confirmed Paul Johnston as its permanent CEO after a successful interim period, while initiating a search for a new CFO to sustain its financial leadership.

Helia Group announces the departure of CEO Pauline Blight-Johnston after five years, appointing CFO Michael Cant as interim CEO amid evolving market conditions. The leadership change signals a strategic pivot for the lender mortgage insurer.

Articore Group reaffirms its FY25 financial guidance while initiating a strategic review to unlock shareholder value, coinciding with the appointment of Vivek Kumar as Group CEO.

Finbar Group has fast-tracked Ronald Chan’s appointment as CEO, aiming to leverage his deep company experience to strengthen its development pipeline and growth strategy.

Patrys Limited has raised $358,362 through a share placement and announced significant board changes, including the appointment of Dr Anton Uvarov and Mr Peter Christie, alongside making the CEO role redundant.

Torque Metals has completed its acquisition of Aston Minerals through a court-approved scheme of arrangement, issuing new shares to Aston securityholders and delisting Aston from the ASX. The combined entity will operate under Torque’s leadership with a refreshed board.

Torque Metals has completed its acquisition of Aston Minerals through court-approved schemes of arrangement, leading to Aston's delisting from the ASX and a reshaped leadership team for the combined entity.

AnteoTech Ltd has completed a strategic review that refocuses its business on commercialising existing products, delivering $1.6 million in annual cost savings and expanding its sales pipeline in battery and life sciences markets.

Opyl Limited unveils a bold strategic pivot to enhance its AI-driven drug discovery platform, leveraging a vast proprietary dataset and leadership upgrades to redefine clinical trial innovation.

Metcash Limited is consolidating its Independent Hardware Group and Total Tools Holdings into a single entity to strengthen its hardware business, while FY25 earnings are poised to slightly exceed market expectations.